Search
Gyre Therapeutics Inc
GYREAdd to Watchlist
6.140USD
-0.110-1.76%
Close 06/22, 16:00（ET）Quotes delayed by 15 min
560.81MMarket Cap
LossP/E TTM
Gyre Therapeutics Inc's Company Valuation
Currency: USD Updated: 2026-06-22The current valuation score of Gyre Therapeutics Inc is 7.77, ranking 201 out of 389 in the Biotechnology & Medical Research industry. Its current P/E ratio is -87.42, which is -316.25% below the recent high of 189.05 and -21.86% above the recent low of -106.53.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.
